Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
RCEL:NASDAQ
AVITA Medical Inc
4,58 USD
+2,23%
(+0,100) 1D
4,60 USD
+0,44% (+0,020)
After hours
Closed: 22-май, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RCEL...
Open
4,61 USD
High
4,85 USD
Low
4,40 USD
Mkt. cap
140,96 млн
Avg. vol.
254,95 миң
Volume
184,23 миң
52-wk high
7,12 USD
52-wk low
3,22 USD
EPS
-1,57 USD
Beta
1,90
Shares outstanding
30,78 млн
No. of employees
226
News stories
From sources across the web
Profile
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersВаленсия, Калифорния, Америка Кошмо Штаттары
Sector-
Websiteavitamedical.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
18,42 млн
17,06 млн
17,62 млн
19,25 млн
Cost of goods sold
3,47 млн
3,19 млн
3,30 млн
3,52 млн
Cost of revenue
3,47 млн
3,19 млн
3,30 млн
3,52 млн
Research and development expenses
5,12 млн
3,75 млн
5,69 млн
5,63 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,98 млн
19,28 млн
19,03 млн
18,90 млн
Operating expense
26,10 млн
23,03 млн
24,72 млн
24,53 млн
Total operating expenses
29,57 млн
26,22 млн
28,02 млн
28,05 млн
Operating income
-11,15 млн
-9,15 млн
-10,41 млн
-8,80 млн
Other non operating income
3,38 млн
-2,15 млн
737,00 миң
-95,00 миң
EBT including unusual items
-9,92 млн
-13,17 млн
-11,64 млн
-10,62 млн
EBT excluding unusual items
-9,02 млн
-12,27 млн
-11,04 млн
-10,32 млн
Income tax expense
4,00 миң
15,00 миң
-17,00 миң
-11,00 миң
Effective tax rate
-0,04%
-0,11%
0,15%
0,10%
Other operating expenses
-
-
-
-
Net income
-9,92 млн
-13,19 млн
-11,62 млн
-10,61 млн
Net profit margin
-53,86%
-77,29%
-65,97%
-55,12%
Earnings per share
-
-
-
-
Interest and investment income
400,00
300,00 миң
200,00 миң
-
Interest expense
-1,25 млн
-1,27 млн
-1,55 млн
-1,42 млн
Net interest expenses
-1,25 млн
-970,20 миң
-1,35 млн
-1,42 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,60 млн
-8,58 млн
-9,76 млн
-8,18 млн
Gain or loss from assets sale
335,00 миң
252,00 миң
5,00 миң
55,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer